Literature DB >> 11333289

Recent trends in cutaneous melanoma incidence among whites in the United States.

A Jemal1, S S Devesa, P Hartge, M A Tucker.   

Abstract

BACKGROUND: It is not yet clear whether increasing melanoma incidence is real or whether recent incidence trends mainly reflect improved diagnosis. To address this question, we examined the most recent melanoma incidence patterns among the white population stratified by sex, age, tumor stage, and tumor thickness by use of data from the Surveillance, Epidemiology, and End Results Program.
METHODS: We examined log-transformed age-specific rates for melanoma by 5-year age groups and time periods by year of diagnosis and birth cohort. Melanoma trends were further examined among broader age groups (<40 years, 40-59 years, and > or =60 years) by tumor stage and tumor thickness. Rates were age-adjusted to the 1970 U.S. standard population, and trends were tested by use of a two-sided Student's t test.
RESULTS: Melanoma incidence increased in females born since the 1960s. From 1974-1975 through 1988-1989, upward trends for the incidence of localized tumors and downward trends for the incidence of distant-stage tumors occurred in the age group under 40 years. In the more recent time period, 1990-1991 through 1996-1997, age specific rates among females compared with males generally remained stable or declined more for distant-stage tumors and increased less for local-stage tumors. Thin tumors (<1 mm) increased statistically significantly in all age groups (P<.05 for all), except in men under age 40 years. In contrast, rates for thick tumors (> or =4 mm) increased statistically significantly (P =.0003) only in males aged 60 years and older.
CONCLUSION: Melanoma incidence may well continue to rise in the United States, at least until the majority of the current population in the middle-age groups becomes the oldest population. The recent trends may reflect increased sunlight exposure.

Entities:  

Mesh:

Year:  2001        PMID: 11333289     DOI: 10.1093/jnci/93.9.678

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  77 in total

1.  Selenium-containing histone deacetylase inhibitors for melanoma management.

Authors:  Raghavendra Gowda; Subbarao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

Review 2.  Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Authors:  Gajanan S Inamdar; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Biochem Pharmacol       Date:  2010-05-09       Impact factor: 5.858

Review 3.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

4.  Sun protection practices among children with a family history of melanoma: a pilot study.

Authors:  Beth A Glenn; Roshan Bastani; L Cindy Chang; Rachna Khanna; Katherine Chen
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

5.  Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure.

Authors:  Thomas B Richards; Christopher J Johnson; Zaria Tatalovich; Myles Cockburn; Melody J Eide; Kevin A Henry; Sue-Min Lai; Sai S Cherala; Youjie Huang; Umed A Ajani
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

6.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 7.  Skin cancer-related prevention and screening behaviors: a review of the literature.

Authors:  Nadine A Kasparian; Jordana K McLoone; Bettina Meiser
Journal:  J Behav Med       Date:  2009-06-12

8.  Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen.

Authors:  Ahmed E Othman; Thomas K Eigentler; Georg Bier; Christina Pfannenberg; Hans Bösmüller; Christian Thiel; Claus Garbe; Konstantin Nikolaou; Bernhard Klumpp
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

9.  Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model.

Authors:  Yong-Jing Gao; Jen-Kun Cheng; Qing Zeng; Zhen-Zhong Xu; Isabelle Decosterd; Xiaoyin Xu; Ru-Rong Ji
Journal:  Exp Neurol       Date:  2009-05-13       Impact factor: 5.330

10.  Changes in the presentation of nodular and superficial spreading melanomas over 35 years.

Authors:  Melanie A Warycha; Paul J Christos; Madhu Mazumdar; Farbod Darvishian; Richard L Shapiro; Russell S Berman; Anna C Pavlick; Alfred W Kopf; David Polsky; Iman Osman
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.